Home LiteratureArticle Details
PMID: 339214 Published · ppublish English Clinical Trial Comparative Study Journal Article Randomized Controlled Trial

A comparison of once and twice daily atenolol in hypertension.

Postgraduate medical journal ·Vol. 53 ·No. 625 ·1977-11-00 ·Pages 679-82

Castleden CM, Dathan JR, George CF

Abstract

The hypertensive action of atenolol has been studied in a randomized double-blind crossover comparison. Twelve patients showed a highly significant reduction in average supine systolic and diastolic blood pressures from pre-treatment values of 196.3/115.9 to 159.1/89.2 mmHg (26.1/15.4 kPa to 22.2/11.9 kPa) after 2 weeks on once daily atenolol. No dose-related reduction in blood pressure was seen and the single 100 mg daily dose was as effective as 100 mg twice daily or 50 mg twice daily. Blood pressures recorded after 2 weeks' atenolol were lower than those obtained at 7 days irrespective of dose.

MeSH Terms
Adult Atenolol/administration & dosage,therapeutic use Blood Pressure/drug effects Clinical Trials as Topic Double-Blind Method Drug Administration Schedule Female Heart Rate/drug effects Humans Hypertension/drug therapy Male Middle Aged Propanolamines/administration & dosage
Chemicals
Propanolamines Atenolol
Authors & Affiliations
3 authors, click to expand affiliations / ORCID
Castleden C M
Dathan J R
George C F
References (5)
5 references, click to expand
  1. The relationship between beta-blockade, hyporeninaemic and hypotensive effect of two beta-blocking agents.
    Postgrad Med J. 1976;52 Suppl 4:102-8 PMID: 9626
  2. Human pharmacokinetic and pharmacodynamic studies on the atenolo (ICI 66,082), a new cardioselective beta-adrenoceptor blocking drug.
    Br J Clin Pharmacol. 1976 Apr;3(2):267-72 PMID: 973955
  3. Raynaud's phenomenon as side effect of beta-blockers in hypertension.
    Br Med J. 1976 Jun 19;1(6024):1498-9 PMID: 6109
  4. Once-daily dosing with Atenolol in patients with mild or moderate hypertension.
    Br Med J. 1976 Apr 24;1(6016):990-1 PMID: 773494
  5. Atenolol in essential hypertension.
    Clin Pharmacol Ther. 1976 May;19(5 Pt 1):502-7 PMID: 776487
Article Info
Journal
Postgraduate medical journal
Abbr.
Postgrad Med J
ISSN
0032-5473
Published
1977-11-00
Pages
679-82
Language
English
Region
England
NLM ID
0234135
PMCID
PMC2496839
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com